Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario.

S. Tomassetti (Forli, Italy), C. Ravaglia (Forli, Italy), A. Wells (London, Italy), M. Marchi (Ravenna, Italy), A. Arcadu (Forlì, Italy), S. Puglisi (Forlì, Italy), L. Donati (Forlì, Italy), A. Dubini (Forlì, Italy), S. Piciucchi (Forlì, Italy), J. Ryu (Rochester, United States of America), C. Klersy (Pavia, Italy), V. Poletti (Forlì, Italy)

Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis

Session: New clinical insights into idiopathic pulmonary fibrosis
Session type: Oral Presentation
Number: 3715

Disease area: Interstitial lung diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Tomassetti (Forli, Italy), C. Ravaglia (Forli, Italy), A. Wells (London, Italy), M. Marchi (Ravenna, Italy), A. Arcadu (Forlì, Italy), S. Puglisi (Forlì, Italy), L. Donati (Forlì, Italy), A. Dubini (Forlì, Italy), S. Piciucchi (Forlì, Italy), J. Ryu (Rochester, United States of America), C. Klersy (Pavia, Italy), V. Poletti (Forlì, Italy). Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario.. 3715

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Source: Eur Respir J, 51 (1) 1702420; 10.1183/13993003.02420-2017 Year: 2018
Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012
Idiopathic pulmonary fibrosis: another step in understanding the burden of this disease Source: Eur Respir J 2016; 48: 26-28 Year: 2016
A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014
Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias? Source: Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020 Year: 2021
Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020
Pharmacotherapy for idiopathic pulmonary fibrosis: current landscape and future potential Source: Eur Respir Rev, 26 (145) 170071; 10.1183/16000617.0071-2017 Year: 2017
The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea Source: International Congress 2015 – IPF: clinical aspects Year: 2015
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation Source: Eur Respir J, 57 (3) 2003111; 10.1183/13993003.03111-2020 Year: 2021
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Source: Eur Respir J 2015; 46: 795-806 Year: 2015
The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF Source: Eur Respir J 2015; 46: 883-886 Year: 2015
Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era? Source: Eur Respir J 2014; 43: 1233-1236 Year: 2014
Idiopathic pulmonary fibrosis: classification, epidemiology, course and prognosis Source: International Congress 2016 – Russia Session Year: 2016
Comorbidities in idiopathic pulmonary fibrosis: an underestimated issue Source: Eur Respir Rev, 28 (153) 190044; 10.1183/16000617.0044-2019 Year: 2019
Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016
Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015
The lived experience of idiopatic pulmonary fibrosis: A qualitative study Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences Year: 2016
A global perspective on acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): results from an international survey Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias Year: 2018
Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study Source: Annual Congress 2007 - The air we breathe at home and at work Year: 2007
Prevalence of chronic ischaemic heart disease in idiopathic pulmonary fibrosis: A single center study Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014